Advertisement
UK markets open in 3 hours 4 minutes
  • NIKKEI 225

    40,742.84
    +162.08 (+0.40%)
     
  • HANG SENG

    17,978.68
    +0.11 (+0.00%)
     
  • CRUDE OIL

    83.88
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,369.40
    0.00 (0.00%)
     
  • DOW

    39,308.00
    -23.90 (-0.06%)
     
  • Bitcoin GBP

    46,328.95
    -1,449.99 (-3.03%)
     
  • CMC Crypto 200

    1,236.69
    -98.23 (-7.36%)
     
  • NASDAQ Composite

    18,188.30
    +159.54 (+0.88%)
     
  • UK FTSE All Share

    4,463.09
    +33.43 (+0.75%)
     

Swedish Exchange Growth Companies With High Insider Ownership July 2024

Amidst a backdrop of mixed performances across major global markets, the Swedish stock market presents unique opportunities for investors interested in growth companies with high insider ownership. Such stocks often suggest a commitment from those who know the company best, aligning closely with shareholder interests especially in uncertain economic times. In this context, understanding the intrinsic qualities that make these stocks appealing can provide a strategic advantage. High insider ownership can be indicative of leadership's confidence in the company's future prospects, potentially making these companies resilient investments during volatile market conditions.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

21.6%

BioArctic (OM:BIOA B)

35.1%

50.9%

Biovica International (OM:BIOVIC B)

12.9%

73.8%

Sileon (OM:SILEON)

33.3%

109.3%

KebNi (OM:KEBNI B)

37.8%

90.4%

edyoutec (NGM:EDYOU)

14.6%

63.1%

InCoax Networks (OM:INCOAX)

18%

104.9%

Calliditas Therapeutics (OM:CALTX)

11.6%

52.9%

Yubico (OM:YUBICO)

37.5%

43.8%

SaveLend Group (OM:YIELD)

23.3%

103.4%

Click here to see the full list of 86 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

ADVERTISEMENT

We'll examine a selection from our screener results.

Betsson

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Betsson AB operates an online gaming business across the Nordic countries, Latin America, Western Europe, Central and Eastern Europe, Central Asia, and other international markets with a market capitalization of approximately SEK 17.46 billion.

Operations: The company generates revenue primarily from its Casinos & Resorts segment, amounting to €974.50 million.

Insider Ownership: 10.9%

Return On Equity Forecast: 23% (2027 estimate)

Betsson, a growth company with significant insider ownership, demonstrates a robust expansion strategy, notably securing its first licenses in Peru's regulated market for online casino and sports betting. This move complements existing operations in Colombia and Argentina, enhancing its regional footprint. Financially, Betsson reported a solid increase in quarterly sales to €248.2 million and net income to €41.3 million as of March 2024. Despite a stable dividend payout totaling €0.645 per share for 2024, the company's dividend track record remains inconsistent. Moreover, insiders have actively purchased more shares than they sold over the past three months, signaling confidence in the company’s prospects despite its revenue forecast growing at a moderate pace (9.9% per year).

OM:BETS B Ownership Breakdown as at Jul 2024
OM:BETS B Ownership Breakdown as at Jul 2024

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ), based in Sweden, focuses on developing biological drugs for central nervous system disorders and has a market capitalization of SEK 20.79 billion.

Operations: The company generates revenue primarily from its biotechnology segment, totaling SEK 252.21 million.

Insider Ownership: 35.1%

Return On Equity Forecast: 32% (2027 estimate)

BioArctic, a Swedish biopharmaceutical company, is expected to become profitable within the next three years with forecasted earnings growth of 50.87% per year and revenue growth significantly outpacing the market at 40.8% annually. Despite trading 67.8% below its fair value estimate, insider transactions have not been substantial in recent months. Recent strategic alliances and product approvals, including for Leqembi® in South Korea, underscore its potential in Alzheimer's treatment but also reflect challenges as seen from its latest quarterly losses (SEK 57.56 million).

OM:BIOA B Earnings and Revenue Growth as at Jul 2024
OM:BIOA B Earnings and Revenue Growth as at Jul 2024

AB Sagax

Simply Wall St Growth Rating: ★★★★☆☆

Overview: AB Sagax (publ) is a property company with operations across Sweden, Finland, France, Benelux, Spain, Germany, and other European countries, boasting a market capitalization of approximately SEK 96.21 billion.

Operations: The company generates its revenue primarily through real estate rentals, totaling SEK 4.47 billion.

Insider Ownership: 28.3%

Return On Equity Forecast: N/A (2027 estimate)

AB Sagax, a Swedish real estate company, has shown robust financial activities with recent green bond issuances totaling €500 million aimed at supporting its sustainability initiatives. Despite a substantial increase in quarterly sales to SEK 1.19 billion and net income rebounding to SEK 1.08 billion, the company's debt levels are concerning as they are not well covered by operating cash flow. While insider ownership remains stable with no significant buying or selling reported recently, shareholder dilution over the past year could raise concerns about future equity value retention. Additionally, although AB Sagax's revenue growth is projected at 9.3% annually—outpacing the Swedish market—its earnings growth is expected to be significantly higher than market averages at 33.5% per year.

OM:SAGA A Ownership Breakdown as at Jul 2024
OM:SAGA A Ownership Breakdown as at Jul 2024

Where To Now?

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:BETS B OM:BIOA B and OM:SAGA A.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com